{"id":6512,"date":"2021-01-13T09:21:27","date_gmt":"2021-01-13T08:21:27","guid":{"rendered":"https:\/\/news.save.ch\/?p=6512"},"modified":"2023-07-22T18:53:52","modified_gmt":"2023-07-22T16:53:52","slug":"zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen","status":null,"type":"post","link":"https:\/\/news.save.ch\/it\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/","title":{"rendered":"Secondo vaccino Covid approvato per la popolazione"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-606 size-medium\" src=\"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-680x454.jpg\" alt=\"Vaccino\" width=\"680\" height=\"454\" srcset=\"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-680x454.jpg 680w, https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-768x512.jpg 768w, https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-18x12.jpg 18w, https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-375x250.jpg 375w, https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus-525x350.jpg 525w, https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg 1000w\" sizes=\"auto, (max-width: 680px) 100vw, 680px\" \/><\/p>\n<p>Il 12 gennaio 2021 anche la Svizzera ha ricevuto 200.000 dosi del vaccino Moderna, gi\u00e0 approvato da Swissmedic. Il vaccino \u00e8 adatto a tutti gli adulti a partire dai 18 anni senza limitazioni di et\u00e0. Insieme al principio attivo di Pfizer e Biontech, la Confederazione ha ora a disposizione mezzo milione di dosi di vaccino per gennaio. La Confederazione ha ordinato 7,5 milioni di unit\u00e0 di Moderna. Secondo l'UFSP, entrambi i vaccini avrebbero un effetto protettivo simile, rispettivamente del 95 e del 94%. La farmacia dell'esercito distribuisce il vaccino ai cantoni.<\/p>\n<p>Come l'ingrediente attivo di Pfizer e Biontech, anche il vaccino Moderna si basa sulla <a href=\"https:\/\/biontech.de\/de\/covid-19-portal\/mRNA-impfstoffe\" target=\"_blank\" rel=\"noopener\">Tecnologia mRNA<\/a>. Si tratta di una specie di molecola messaggera che trasporta le istruzioni per la produzione delle proteine. Questo \"messaggero di istruzioni per la costruzione\" trasmette virtualmente le informazioni necessarie alle cellule del corpo su come devono produrre una proteina del virus. Non appena la proteina viene prodotta nell'organismo, il sistema immunitario la riconosce come estranea e produce anticorpi contro il virus. Tuttavia, secondo l'UFSP, per una protezione vaccinale ottimale sono necessarie due dosi a intervalli di circa quattro settimane. Il primo lotto di vaccino Moderna sar\u00e0 consegnato nei prossimi giorni.<\/p>\n<p>Finora, la Confederazione ha acquistato un totale di oltre 15 milioni di dosi di vaccino da tre produttori di vaccini; oltre a Moderna (per un totale di circa 7,5 milioni di dosi di vaccino) e Pfizer\/Biontech (circa 3 milioni di dosi di vaccino), questi includono la societ\u00e0 farmaceutica Astra Zeneca (circa 5,3 milioni di dosi di vaccino). Il vaccino di Astra Zeneca \u00e8 ancora in fase di approvazione presso Swissmedic. La Confederazione \u00e8 in trattative con altri produttori di vaccini. Allo stesso tempo, la Svizzera sta partecipando al progetto internazionale <a href=\"https:\/\/www.who.int\/initiatives\/act-accelerator\/covax\" target=\"_blank\" rel=\"noopener\">\"Iniziativa Covax\"<\/a>L'obiettivo \u00e8 fornire l'accesso ai vaccini fino al 20% della popolazione svizzera e consentire anche ai Paesi economicamente pi\u00f9 deboli di avere accesso ai vaccini.<\/p>\n<h2>Gruppi a rischio e altri gruppi target in base alla priorit\u00e0<\/h2>\n<p>La maggior parte dei cantoni ha gi\u00e0 allestito centri di vaccinazione; le squadre mobili vengono utilizzate anche nelle case di riposo e nelle case di cura. Secondo l'UFSP, la strategia nazionale di vaccinazione d\u00e0 la priorit\u00e0 alla vaccinazione di persone particolarmente a rischio, ovvero anziani e persone con patologie preesistenti. La seconda priorit\u00e0 \u00e8 la vaccinazione degli operatori sanitari, mentre la terza \u00e8 la vaccinazione delle persone che vivono con persone particolarmente a rischio. In quarta priorit\u00e0, le persone che vivono in strutture comuni dove il rischio di infezione e di focolai \u00e8 maggiore (ad esempio le case per disabili) e il loro personale.<\/p>\n<p>Tutti gli altri adulti potranno essere vaccinati non appena saranno disponibili dosi sufficienti di vaccino. I bambini e le donne in gravidanza non sono ancora inclusi nei gruppi target della strategia di vaccinazione, poich\u00e9 i dati degli studi corrispondenti per questi gruppi non sono ancora disponibili. Non \u00e8 prevista una vaccinazione obbligatoria. La vaccinazione Covid 19 \u00e8 gratuita per la popolazione.<\/p>\n<p><em>Fonte: BAG<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Am 12. Januar 2021 hat die Schweiz nun auch vom Moderna-Impfsoff 200&#8217;000 Dosen erhalten, der bereits die Zulassung durch Swissmedic erhalten hat. Der Impfstoff sei ohne Alterseinschr\u00e4nkung f\u00fcr alle Erwachsenen ab 18 Jahren geeignet. Zusammen mit dem Wirkstoff von Pfizer und Biontech stehen dem Bund nun im Januar eine halbe Millionen Impfdosen zur Verf\u00fcgung. Von [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":606,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pgc_sgb_lightbox_settings":"","footnotes":""},"categories":[1,3314],"tags":[700,1729,1797,632,1879,2296,5856,2556,5791,2674,1079],"class_list":["post-6512","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","category-health-safety","tag-bag","tag-bagatellunfaelle","tag-biontech","tag-covid-19","tag-covid-19-virus","tag-impfstoff","tag-impfstrategie","tag-moderna","tag-mrna-technologie","tag-pfizer","tag-schweiz"],"acf":[],"hkrextid":null,"publication":null,"issue":null,"workflow":null,"startPage":null,"spitzmarke":null,"_posts_by_tag_page_fields":{"widget_title":"","widget_tags":""},"_at_widget":"1","_yoast_wpseo_primary_category":"1","_yoast_wpseo_focuskw_text_input":null,"_yoast_wpseo_opengraph-image":null,"_yoast_wpseo_opengraph-description":null,"_yoast_wpseo_opengraph-title":null,"enclosure":null,"_yoast_wpseo_twitter-title":null,"_yoast_wpseo_twitter-description":null,"_yoast_wpseo_twitter-image":null,"_wp_old_slug":null,"_yoast_wpseo_title":null,"_yoast_wpseo_canonical":null,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen - Save<\/title>\n<meta name=\"description\" content=\"Die Heilmittelbeh\u00f6rde Swissmedic hat am 12. Januar 2021 den zweiten Covid-19-Impfstoff f\u00fcr den Schweizer Markt zugelassen. Damit stehen in der Schweiz nun im Januar eine halbe Million Impfdosen bereit. Die erste Lieferung von 200&#039;000 Dosen \u00abModerna\u00bb erfolge in den n\u00e4chsten Tagen. Die Armeeapotheke verteilt den Impfstoff an die Kantone.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/news.save.ch\/it\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen - Save\" \/>\n<meta property=\"og:description\" content=\"Die Heilmittelbeh\u00f6rde Swissmedic hat am 12. Januar 2021 den zweiten Covid-19-Impfstoff f\u00fcr den Schweizer Markt zugelassen. Damit stehen in der Schweiz nun im Januar eine halbe Million Impfdosen bereit. Die erste Lieferung von 200&#039;000 Dosen \u00abModerna\u00bb erfolge in den n\u00e4chsten Tagen. Die Armeeapotheke verteilt den Impfstoff an die Kantone.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/news.save.ch\/it\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/\" \/>\n<meta property=\"og:site_name\" content=\"Save\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T08:21:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-22T16:53:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simon Gr\u00f6flin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Gr\u00f6flin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/\"},\"author\":{\"name\":\"Simon Gr\u00f6flin\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#\\\/schema\\\/person\\\/ad4ef21102fd6125312409ac57d5296d\"},\"headline\":\"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen\",\"datePublished\":\"2021-01-13T08:21:27+00:00\",\"dateModified\":\"2023-07-22T16:53:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg\",\"keywords\":[\"BAG\",\"Bagatellunf\u00e4lle\",\"Biontech\",\"Covid-19\",\"Covid-19-Virus\",\"Impfstoff\",\"Impfstrategie\",\"Moderna\",\"mRNA-Technologie\",\"Pfizer\",\"Schweiz\"],\"articleSection\":[\"ALLGEMEIN\",\"HEALTH &amp; SAFETY\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/\",\"url\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/\",\"name\":\"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen - Save\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg\",\"datePublished\":\"2021-01-13T08:21:27+00:00\",\"dateModified\":\"2023-07-22T16:53:52+00:00\",\"description\":\"Die Heilmittelbeh\u00f6rde Swissmedic hat am 12. Januar 2021 den zweiten Covid-19-Impfstoff f\u00fcr den Schweizer Markt zugelassen. Damit stehen in der Schweiz nun im Januar eine halbe Million Impfdosen bereit. Die erste Lieferung von 200'000 Dosen \u00abModerna\u00bb erfolge in den n\u00e4chsten Tagen. Die Armeeapotheke verteilt den Impfstoff an die Kantone.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg\",\"contentUrl\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2016\\\/12\\\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Masern-Schutzl\u00fccken schliessen und gegen die saisonale Grippe impfen: Am 6. November braucht es dazu keine Anmeldung.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/news.save.ch\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/news.save.ch\\\/de\\\/\",\"name\":\"Save\",\"description\":\"Schweizer Fachzeitschrift f\u00fcr Sicherheit\",\"publisher\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/news.save.ch\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#organization\",\"name\":\"Sicherheitsforum\",\"url\":\"https:\\\/\\\/news.save.ch\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Logo_SF_2012.png\",\"contentUrl\":\"https:\\\/\\\/news.save.ch\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Logo_SF_2012.png\",\"width\":1100,\"height\":91,\"caption\":\"Sicherheitsforum\"},\"image\":{\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/news.save.ch\\\/de\\\/#\\\/schema\\\/person\\\/ad4ef21102fd6125312409ac57d5296d\",\"name\":\"Simon Gr\u00f6flin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g\",\"caption\":\"Simon Gr\u00f6flin\"},\"url\":\"https:\\\/\\\/news.save.ch\\\/it\\\/author\\\/simon-groeflin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Approvato il secondo vaccino Covid per la popolazione - Save","description":"L'Istituto per gli agenti terapeutici Swissmedic ha approvato il secondo vaccino Covid 19 per il mercato svizzero il 12 gennaio 2021. Ci\u00f2 significa che mezzo milione di dosi di vaccino saranno ora disponibili in Svizzera nel mese di gennaio. La prima consegna di 200.000 dosi di \"Moderna\" avverr\u00e0 nei prossimi giorni. La farmacia dell'esercito distribuisce il vaccino ai cantoni.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/news.save.ch\/it\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/","og_locale":"it_IT","og_type":"article","og_title":"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen - Save","og_description":"Die Heilmittelbeh\u00f6rde Swissmedic hat am 12. Januar 2021 den zweiten Covid-19-Impfstoff f\u00fcr den Schweizer Markt zugelassen. Damit stehen in der Schweiz nun im Januar eine halbe Million Impfdosen bereit. Die erste Lieferung von 200'000 Dosen \u00abModerna\u00bb erfolge in den n\u00e4chsten Tagen. Die Armeeapotheke verteilt den Impfstoff an die Kantone.\u00a0","og_url":"https:\/\/news.save.ch\/it\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/","og_site_name":"Save","article_published_time":"2021-01-13T08:21:27+00:00","article_modified_time":"2023-07-22T16:53:52+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg","type":"image\/jpeg"}],"author":"Simon Gr\u00f6flin","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Simon Gr\u00f6flin","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#article","isPartOf":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/"},"author":{"name":"Simon Gr\u00f6flin","@id":"https:\/\/news.save.ch\/de\/#\/schema\/person\/ad4ef21102fd6125312409ac57d5296d"},"headline":"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen","datePublished":"2021-01-13T08:21:27+00:00","dateModified":"2023-07-22T16:53:52+00:00","mainEntityOfPage":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/"},"wordCount":450,"publisher":{"@id":"https:\/\/news.save.ch\/de\/#organization"},"image":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#primaryimage"},"thumbnailUrl":"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg","keywords":["BAG","Bagatellunf\u00e4lle","Biontech","Covid-19","Covid-19-Virus","Impfstoff","Impfstrategie","Moderna","mRNA-Technologie","Pfizer","Schweiz"],"articleSection":["ALLGEMEIN","HEALTH &amp; SAFETY"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/","url":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/","name":"Approvato il secondo vaccino Covid per la popolazione - Save","isPartOf":{"@id":"https:\/\/news.save.ch\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#primaryimage"},"image":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#primaryimage"},"thumbnailUrl":"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg","datePublished":"2021-01-13T08:21:27+00:00","dateModified":"2023-07-22T16:53:52+00:00","description":"L'Istituto per gli agenti terapeutici Swissmedic ha approvato il secondo vaccino Covid 19 per il mercato svizzero il 12 gennaio 2021. Ci\u00f2 significa che mezzo milione di dosi di vaccino saranno ora disponibili in Svizzera nel mese di gennaio. La prima consegna di 200.000 dosi di \"Moderna\" avverr\u00e0 nei prossimi giorni. La farmacia dell'esercito distribuisce il vaccino ai cantoni.\u00a0","breadcrumb":{"@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#primaryimage","url":"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg","contentUrl":"https:\/\/news.save.ch\/wp-content\/uploads\/2016\/12\/Impftag-gegen-Grippe-und-Masern_safety-plus.jpg","width":1000,"height":667,"caption":"Masern-Schutzl\u00fccken schliessen und gegen die saisonale Grippe impfen: Am 6. November braucht es dazu keine Anmeldung."},{"@type":"BreadcrumbList","@id":"https:\/\/news.save.ch\/zweiter-covid-impfstoff-fuer-die-bevoelkerung-zugelassen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/news.save.ch\/de\/"},{"@type":"ListItem","position":2,"name":"Zweiter Covid-Impfstoff f\u00fcr die Bev\u00f6lkerung zugelassen"}]},{"@type":"WebSite","@id":"https:\/\/news.save.ch\/de\/#website","url":"https:\/\/news.save.ch\/de\/","name":"Risparmiare","description":"Rivista svizzera specializzata in sicurezza","publisher":{"@id":"https:\/\/news.save.ch\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/news.save.ch\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/news.save.ch\/de\/#organization","name":"Forum sulla sicurezza","url":"https:\/\/news.save.ch\/de\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/news.save.ch\/de\/#\/schema\/logo\/image\/","url":"https:\/\/news.save.ch\/wp-content\/uploads\/2022\/06\/Logo_SF_2012.png","contentUrl":"https:\/\/news.save.ch\/wp-content\/uploads\/2022\/06\/Logo_SF_2012.png","width":1100,"height":91,"caption":"Sicherheitsforum"},"image":{"@id":"https:\/\/news.save.ch\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/news.save.ch\/de\/#\/schema\/person\/ad4ef21102fd6125312409ac57d5296d","name":"Simon Gr\u00f6flin","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6ddceb80eb734354635539e0ea5140bb7c41e42de7c45c9a2ab9921b5d5c9a83?s=96&d=mm&r=g","caption":"Simon Gr\u00f6flin"},"url":"https:\/\/news.save.ch\/it\/author\/simon-groeflin\/"}]}},"_links":{"self":[{"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/posts\/6512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/comments?post=6512"}],"version-history":[{"count":2,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/posts\/6512\/revisions"}],"predecessor-version":[{"id":21254,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/posts\/6512\/revisions\/21254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/media\/606"}],"wp:attachment":[{"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/media?parent=6512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/categories?post=6512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.save.ch\/it\/wp-json\/wp\/v2\/tags?post=6512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}